Fate Therapeutics, Inc.
NasdaqGM:FATE
$ 3.90
$0.00 (0.00%)
$ 3.90
$0.00 (0.00%)
End-of-day quote: 05/17/2024

FATE - Fate Therapeutics Stock Prediction 2025 - 2030

11 years of reliable Fate Therapeutics stock forecast. The Wall Street analysts predict Outperform for FATE. See at a glance whether NasdaqGM:FATE will rise in the future.

$0.00
Forecast 2023
$4.63
Forecast 2025
$7.88
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$4.63
Forecast 2030
$7.88
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.8
Price-to-book Ratio
1.04
Market Cap
0.46B
TEV
0.18 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$6.23

Fate Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Fate Therapeutics Stock Forecast 2023

$6.00

In the last five quarters, Fate Therapeutics’s Price Target has fallen from $59.85 to $6.23 - a -89.59% decrease. Sixteen analysts predict that Fate Therapeutics’s share price will fall in the coming year, reaching $6.00. This would represent a decrease of -3.69%.

53.85%
53.85
Last update: 05/20/2024

Highest Price Target $12.00

Average Price Target $6.00

Lowest Price Target $4.00

Fate Therapeutics Stock Forecast 2025

Stock Prediction for the Price of One Fate Therapeutics Share in Jan 2025.

In Jan 2025 analysts predict a share price of $4.21. An increase of 7.86% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Feb 2025.

In Feb 2025 analysts predict a share price of $4.25. An increase of 8.86% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Mar 2025.

In Mar 2025 analysts predict a share price of $4.28. An increase of 9.86% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Apr 2025.

In Apr 2025 analysts predict a share price of $4.32. An increase of 10.85% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in May 2025.

In May 2025 analysts predict a share price of $4.36. An increase of 11.85% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Jun 2025.

In Jun 2025 analysts predict a share price of $4.40. An increase of 12.85% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Jul 2025.

In Jul 2025 analysts predict a share price of $4.44. An increase of 13.84% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Aug 2025.

In Aug 2025 analysts predict a share price of $4.48. An increase of 14.84% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Sep 2025.

In Sep 2025 analysts predict a share price of $4.52. An increase of 15.84% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Oct 2025.

In Oct 2025 analysts predict a share price of $4.56. An increase of 16.83% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Nov 2025.

In Nov 2025 analysts predict a share price of $4.60. An increase of 17.83% compared to today's share price.

Stock Prediction for the Price of One Fate Therapeutics Share in Dec 2025.

In Dec 2025 analysts predict a share price of $4.63. An increase of 18.83% compared to today's share price.

Fate Therapeutics Stock Predictions 2030

Fate Therapeutics Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $7.15. An increase of 83.32% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $7.22. An increase of 85.01% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $7.28. An increase of 86.71% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $7.35. An increase of 88.4% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $7.41. An increase of 90.09% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $7.48. An increase of 91.79% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $7.55. An increase of 93.48% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $7.61. An increase of 95.17% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $7.68. An increase of 96.87% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $7.74. An increase of 98.56% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $7.81. An increase of 100.26% compared to the previous month's estimate.

Fate Therapeutics Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $7.88. An increase of 101.95% compared to the previous month's estimate.

P/E
0.00
Beta
1.8
Price-to-book Ratio
1.04
Market Cap
0.46B
TEV
0.18 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$6.23

Fate Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Fate Therapeutics, Inc.?

The following analysts have recently covered Fate Therapeutics:

Barclays
BMO Capital Markets Equity Research
BofA Global Research
Cantor Fitzgerald & Co.
Citigroup Inc
Guggenheim Securities, LLC
H.C. Wainwright & Co.
Jefferies LLC
Marktfeld
Mizuho Securities USA LLC
Morgan Stanley
Oppenheimer & Co. Inc.
Piper Sandler Companies
Stifel
Wedbush Securities Inc.
Wells Fargo Securities, LLC
Needham & Company
Baird
Canaccord Genuity
Goldman Sachs
Leerink Partners LLC
TD Cowen
Citigroup Inc. Research
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Fate Therapeutics, Inc.?

The following sell-side analysts have recently covered Fate Therapeutics:

Lawson, Peter Richard
Darout, Etzer
Ahmad, Tazeen
Nochomovitz, Yigal Dov
Schmidt, Michael Werner
Burns, Robert John
Yee, Michael Jonathan
Paraskevopoulos, Michail
Ulz, Michael Eric
Biegler, Matthew Cornell
Tenthoff, Edward Andrew
Burnett, Benjamin Jay
Nierengarten, David Matthew
Wang Watsek, Li
Graybosch, Daina Michelle
Blum, Gil Joseph
Allen, Jack Kilgannon
Maughan, William Patrick
Tan, Andrea R.
Zhu, Yanan
Syed, Salim Qader
Bancroft, Tara A.
(This information refers to the last 90 days.)